skip to main content


Analyst Coverage

This page gives details of the analysts who write research on Evgen Pharma.

It also gives access to the research on the company written by Hardman & Co.

Analyst Details

Company Analyst
Northland Capital Partners Vadim Alexandre
Hardman & Co Martin Hall

Commissioned Research

Company Date Description Download
Hardman & Co 29th June 2018 2018, A Pivotal Year Download Research
Hardman & Co 11th December 2017 Interims - increased funding to the end of Phase II trials Download Research
Hardman & Co 21st June 2017 Clinical trials update Download Research
Hardman & Co 14th December 2016 Interims - update on clinical progress Download Research
Hardman & Co 29th November 2016 Harnessing the clinical potential of sulforaphane Download Research